BioPharm International, May 2007

Features

Outsourcing: Transition from Business Process Outsourcing to Knowledge Process Outsourcing

By Hazel Aranha , Scott M. Wheelwright

By outsourcing high-end processes that demand advanced analytical and technical skills, biopharm companies are reaping substantial savings.

Chromatography: A Two-Column Process To Purify Antibodies Without Protein A

By G.M. Ferreira , J. Dembecki , K. Patel , Alahari Arunakumari, PhD

This flexible setup minimizes the number of purification process steps, buffers, and process components.

Separation & Purification: Endotoxin Reduction Using Disposable Membrane Adsorption Technology in cGMP Manufacturing

By Andrew Clutterbuck , James Kenworthy , John Liddell

Membrane-based chromatography technologies sometimes offer advantages over resin-based technologies.

Columns and Departments

Outsourcing Insights: Booming Biopharma Pipeline Straining CRO Capacity

By Jim Miller

Venture capital insiders say that the flow of funds into biopharma shouldcontinue, driven by the large amount of money available for investment.

Final Word: Political Will is the Backbone of Regulation Enforcement

By Steven S. Kuwahara

Lax enforcement arising from a lack of political will creates the potential for a loss of public confidence.

From the Editor: Score One for Preparedness

By Laura Bush

Fortunately for all of us, not everyone's head is in the sand.

China Today: Intellectual Property Protection in China: Does it Warrant Worry?

By Eric S. Langer

China's central government is aware of the need to improve intellectual property protection and enforcement.

Regulatory Beat: Campaign Accelerates for Follow-on Biologics

By Jill Wechsler

The information provided by analytical testing is important in determining whether additional clinical trails are necessary to bring a follow-on to market.